BridgeBio Pharma, Inc. (BBIO)

74.08 -2.10 (-2.76%) USD  |  NASDAQ  |  Apr 22, 15:43
More

BridgeBio Pharma Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
Pfizer Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Insmed, Inc. Upgrade
Eli Lilly & Co. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade